← Leaderboards
Benita S Katzenellenbogen
University Of Illinois Urbana-Champaign
$5,921,292
Attributed
$7,782,389
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $581.9K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,782,389 · 4
By mechanism
R01$6,550,041 · 3
U54$1,232,348 · 1
Top collaborators
- John A. Katzenellenbogen6 shared
- Kendall W Nettles6 shared
Most similar at University Of Illinois Urbana-Champaign
Same institution · by research overlap
- David J Shapiro$9,694,095
- John A. Katzenellenbogen$15,325,493
- Ann Nardulli$6,435,714
- Milan K Bagchi$7,406,430
- Sergei A Dikanov$2,560,076
Others in their field
Top investigators on “Estrogen Receptors”
- Susan E. Hankinson · University Of Massachusetts Amherst$30,736,590
- David Heimbrook · Leidos Biomedical Research, Inc.$29,594,272
- Bert W O'Malley · Baylor College Of Medicine$28,464,172
- Norman Wolmark · Nsabp Foundation, Inc.$27,593,122
- Howard N Hodis · University Of Southern California$24,496,214
- Donald P McDonnell · Duke University$19,513,822
Research focus
Estrogen ReceptorsGene ExpressionHormonesKnock-OutTissuesGenesMolecularIn VivoEstradiolReceptorEstrogensUterusTamoxifenGene Induction /RepressionGenetic TranscriptionBreast NeoplasmsPolymerase Chain ReactionPhenotypeMutantGene TargetingHormone Regulation /Control MechanismBaseBreast Cancer CellAffect
Grant awards (23)
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor$548,236
R01 · FY2022 · CA
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor$559,423
R01 · FY2021 · CA
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor$1
R01 · FY2021 · CA
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor$559,424
R01 · FY2020 · CA
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor$542,640
R01 · FY2019 · CA
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor$581,922
R01 · FY2018 · CA
Nuclear Receptor Coregulators in Implantation and Uterine Function$236,941
U54 · FY2012 · HD · contact PI
Nuclear Receptor Coregulators in Implantation and Uterine Function$220,772
U54 · FY2011 · HD · contact PI
Nuclear Receptor Coregulators in Implantation and Uterine Function$266,353
U54 · FY2010 · HD · contact PI
Nuclear Receptor Coregulators in Implantation and Uterine Function$261,208
U54 · FY2009 · HD · contact PI
ANTIESTROGENS: MECHANISM OF ANTAGONIST ACTION$322,811
R01 · FY2008 · CA · contact PI
Nuclear Receptor Coregulators in Implantation and Uterine Function$247,074
U54 · FY2008 · HD · contact PI
ANTIESTROGENS: MECHANISM OF ANTAGONIST ACTION$322,916
R01 · FY2007 · CA · contact PI
ANTIESTROGENS: MECHANISM OF ANTAGONIST ACTION$321,021
R01 · FY2006 · CA · contact PI
ANTIESTROGENS: MECHANISM OF ANTAGONIST ACTION$306,350
R01 · FY2005 · CA
ANTIESTROGENS: MECHANISM OF ANTAGONIST ACTION$306,452
R01 · FY2004 · CA
ANTIESTROGENS--MECHANISM OF ANTAGONIST ACTION$323,095
R01 · FY2003 · CA
DOMINANT NEGATIVE ESTROGEN RECEPTORS AND BREAST CANCER$319,466
R01 · FY2002 · CA
ANTIESTROGENS--MECHANISM OF ANTAGONIST ACTION$313,830
R01 · FY2002 · CA
DOMINANT NEGATIVE ESTROGEN RECEPTORS AND BREAST CANCER$310,214
R01 · FY2001 · CA
ANTIESTROGENS--MECHANISM OF ANTAGONIST ACTION$309,871
R01 · FY2001 · CA
DOMINANT NEGATIVE ESTROGEN RECEPTORS AND BREAST CANCER$301,232
R01 · FY2000 · CA
ANTIESTROGENS--MECHANISM OF ANTAGONIST ACTION$301,137
R01 · FY2000 · CA